Thomas Reissman

Title: Thomas Reissman: Innovator in Long-Acting Injection Suspensions

Introduction

Thomas Reissman is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-acting injection suspensions. His work has implications for the treatment of various medical conditions, showcasing his expertise and innovative spirit.

Latest Patents

Reissman holds a patent for "Long-acting injection suspensions and a process for their preparation." This patent focuses on poorly soluble salts of LHRH analogues, such as cetrorelix embonate, which exhibit an intrinsic sustained release effect within a grain size range of 5 µm to 200 µm. This innovation is crucial for improving the efficacy and delivery of medications.

Career Highlights

Throughout his career, Thomas Reissman has been associated with Asta Medica Aktiengesellschaft, a company known for its advancements in pharmaceutical research and development. His work at Asta Medica has allowed him to explore and implement innovative solutions in drug formulation.

Collaborations

Reissman has collaborated with esteemed colleagues, including Jurgen Engel and Karin Klokkers-Bethke. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Thomas Reissman is a distinguished inventor whose work in long-acting injection suspensions has made a significant impact in the pharmaceutical industry. His innovative contributions continue to influence the field and improve patient care.